Global Stomach Cancer Drugs Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Stomach Cancer Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Chemo Drugs
- 1.4.3 Targeted Therapy Drugs
- 1.4.4 Biological Therapies
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Stomach Cancer Drugs Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Stomach Cancer Drugs Market Size
- 2.2 Stomach Cancer Drugs Growth Trends by Regions
- 2.2.1 Stomach Cancer Drugs Market Size by Regions (2014-2025)
- 2.2.2 Stomach Cancer Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Stomach Cancer Drugs Market Size by by Players
- 3.1.1 Global Stomach Cancer Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Stomach Cancer Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Stomach Cancer Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Stomach Cancer Drugs Key Players Head office and Area Served
- 3.3 Key Players Stomach Cancer Drugs Product/Solution/Service
- 3.4 Date of Enter into Stomach Cancer Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Stomach Cancer Drugs Market Size by Type (2014-2019)
- 4.2 Global Stomach Cancer Drugs Market Size by Application (2014-2019)
5 United States
- 5.1 United States Stomach Cancer Drugs Market Size (2014-2019)
- 5.2 Stomach Cancer Drugs Key Players in United States
- 5.3 United States Stomach Cancer Drugs Market Size by Type
- 5.4 United States Stomach Cancer Drugs Market Size by Application
6 Europe
- 6.1 Europe Stomach Cancer Drugs Market Size (2014-2019)
- 6.2 Stomach Cancer Drugs Key Players in Europe
- 6.3 Europe Stomach Cancer Drugs Market Size by Type
- 6.4 Europe Stomach Cancer Drugs Market Size by Application
7 China
- 7.1 China Stomach Cancer Drugs Market Size (2014-2019)
- 7.2 Stomach Cancer Drugs Key Players in China
- 7.3 China Stomach Cancer Drugs Market Size by Type
- 7.4 China Stomach Cancer Drugs Market Size by Application
8 Japan
- 8.1 Japan Stomach Cancer Drugs Market Size (2014-2019)
- 8.2 Stomach Cancer Drugs Key Players in Japan
- 8.3 Japan Stomach Cancer Drugs Market Size by Type
- 8.4 Japan Stomach Cancer Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Stomach Cancer Drugs Market Size (2014-2019)
- 9.2 Stomach Cancer Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Stomach Cancer Drugs Market Size by Type
- 9.4 Southeast Asia Stomach Cancer Drugs Market Size by Application
10 India
- 10.1 India Stomach Cancer Drugs Market Size (2014-2019)
- 10.2 Stomach Cancer Drugs Key Players in India
- 10.3 India Stomach Cancer Drugs Market Size by Type
- 10.4 India Stomach Cancer Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Stomach Cancer Drugs Market Size (2014-2019)
- 11.2 Stomach Cancer Drugs Key Players in Central & South America
- 11.3 Central & South America Stomach Cancer Drugs Market Size by Type
- 11.4 Central & South America Stomach Cancer Drugs Market Size by Application
12 International Players Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Stomach Cancer Drugs Introduction
- 12.1.4 Pfizer Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.1.5 Pfizer Recent Development
- 12.2 Eli Lilly
- 12.2.1 Eli Lilly Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Stomach Cancer Drugs Introduction
- 12.2.4 Eli Lilly Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.2.5 Eli Lilly Recent Development
- 12.3 Sanofi
- 12.3.1 Sanofi Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Stomach Cancer Drugs Introduction
- 12.3.4 Sanofi Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.3.5 Sanofi Recent Development
- 12.4 Kuhnil Pharm
- 12.4.1 Kuhnil Pharm Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Stomach Cancer Drugs Introduction
- 12.4.4 Kuhnil Pharm Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.4.5 Kuhnil Pharm Recent Development
- 12.5 Merck & Co
- 12.5.1 Merck & Co Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Stomach Cancer Drugs Introduction
- 12.5.4 Merck & Co Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.5.5 Merck & Co Recent Development
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Stomach Cancer Drugs Introduction
- 12.6.4 AstraZeneca Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.6.5 AstraZeneca Recent Development
- 12.7 Novartis
- 12.7.1 Novartis Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Stomach Cancer Drugs Introduction
- 12.7.4 Novartis Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.7.5 Novartis Recent Development
- 12.8 Taiho Pharmaceutical
- 12.8.1 Taiho Pharmaceutical Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Stomach Cancer Drugs Introduction
- 12.8.4 Taiho Pharmaceutical Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.8.5 Taiho Pharmaceutical Recent Development
- 12.9 Mylan
- 12.9.1 Mylan Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Stomach Cancer Drugs Introduction
- 12.9.4 Mylan Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.9.5 Mylan Recent Development
- 12.10 Celgene Corporation
- 12.10.1 Celgene Corporation Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Stomach Cancer Drugs Introduction
- 12.10.4 Celgene Corporation Revenue in Stomach Cancer Drugs Business (2014-2019)
- 12.10.5 Celgene Corporation Recent Development
- 12.11 Boston Biomedical
- 12.12 Jiangsu Hengrui Medicine
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Stomach Cancer Drugs are used to treat stomach malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
In 2018, the global Stomach Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Stomach Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stomach Cancer Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
Eli Lilly
Sanofi
Kuhnil Pharm
Merck & Co
AstraZeneca
Novartis
Taiho Pharmaceutical
Mylan
Celgene Corporation
Boston Biomedical
Jiangsu Hengrui Medicine
Market segment by Type, the product can be split into
Chemo Drugs
Targeted Therapy Drugs
Biological Therapies
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Stomach Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Stomach Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Stomach Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.